Steminent Biotherapeutics Inc Sustainability Reports
Steminent Biotherapeutics Inc. focuses on the research, clinical development, and commercialization of stem cell-derived therapeutics. The company targets neurodegenerative and rare diseases using its proprietary mesenchymal stem cell platform.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG012XRDTN5
2 reports from 2022 to 2024